IPN.FR - Daily
Our expectations: Upward trend and price after adjustment in a support area, providing a good opportunity to add to long positions or build new ones. Stop Loss: 137.90
Alternative Scenario: Breaking the main trend and keeping the price below the support zone will break the positive scenario and are more likely to see a decline in the stock price.
Comment: Upward trend, correction to support zone formed by main upside diagonal, horizontal, 50SMA and 23.6% Fibonacci trend correction. Price Action: A Pin bar in a support zone that clearly shows the desire of the bulls to buy from the current values. 50 and 200SMA remain beached - the trend remains in place. The CCI14 crosses -100 from the bottom up while the CCI50 remains slightly below 0 - the probable end of the corrective pulse.
The positioning options are 2, immediately upon the opening of European exchanges and after 50% correction of the pin bar.
Ipsen S.A. is a French pharmaceutical company in the healthcare sector, whose companies are seen as a "shelter" during short-term stock market uncertainty. The deepening disputes between the US, China and Canada will most likely lead to a temporary capital allocation to the health sector, which has already achieved good growth rates over recent years.
Read more:
25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256
World Financial Markets - 0700 17 600 Varchev Exchange - 0700 115 44
Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.
Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006
The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
Disclaimer:
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.